Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin

被引：21

作者：

Kim, Ahwon ^{[1
]}

Keam, Bhumsuk ^{[2
]}

Cheun, Hyeon ^{[3
]}

Lee, Soon-Tae ^{[1
]}

Gook, Hyung Seok ^{[1
]}

Han, Moon-Ku ^{[4
]}

机构：

[1] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea

[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

[3] Seoul Natl Univ, Coll Med, Seoul, South Korea

[4] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea

来源：

JOURNAL OF CLINICAL NEUROLOGY | 2019年 / 15卷 / 02期

关键词：

PARANEOPLASTIC SYNDROMES; ATEZOLIZUMAB; BLADDER; CANCER;

D O I：

10.3988/jcn.2019.15.2.259

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：259 / 261

页数：3

共 13 条

[1]

Blackmon JT., 2016, J Neurol Neuromedicine, V1, P39, DOI [10.29245/2572.942X/2016/4.1040, DOI 10.29245/2572.942X/2016/4.1040]

[2] Paraneoplastic syndromes involving the nervous system [J].

Darnell, RB ;

Posner, JB .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) :1543-1554

[3] Neurologic complications of immune checkpoint inhibitors [J].

Fellner, Avi ;

Makranz, Chen ;

Lotem, Michal ;

Bokstein, Felix ;

Taliansky, Alisa ;

Rosenberg, Shai ;

Blumenthal, Deborah T. ;

Mandel, Jacob ;

Fichman, Suzana ;

Kogan, Elena ;

Steiner, Israel ;

Siegal, Tali ;

Lossos, Alexander ;

Yust-Katz, Shlomit .

JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (03) :601-609

[4]

Food and Drug Administration, 2018, TECENTRIQ AT INJ INT

[5] Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis [J].

Hottinger, Andreas F. ;

de Micheli, Rita ;

Guido, Vanessa ;

Karampera, Alexandra ;

Hagmann, Patric ;

Du Pasquier, Renaud .

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2018, 5 (02)

[6] Rituximab for nivolumab plus ipilimumab-induced encephalitis in a small-cell lung cancer patient [J].

Ito, M. ;

Fujiwara, S. ;

Fujimoto, D. ;

Mori, R. ;

Yoshimura, H. ;

Hata, A. ;

Kohara, N. ;

Tomii, K. .

ANNALS OF ONCOLOGY, 2017, 28 (09) :2318-2319

[7] Atezolizumab: A novel PD-L1 inhibitor in cancer therapy with a focus in bladder and non-small cell lung cancers [J].

Krishnamurthy, A. ;

Jimeno, A. .

DRUGS OF TODAY, 2017, 53 (04) :217-237

[8] Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature [J].

Laserna, Andres ;

Tummala, Sudhakar ;

Patel, Neel ;

El Hamouda, Diaa Eldin Mohamed ;

Gutierrez, Cristina .

SAGE OPEN MEDICAL CASE REPORTS, 2018, 6

[9] Atezolizumab-induced Encephalitis in Metastatic Bladder Cancer: A Case Report and Review of the Literature [J].

Levine, Jeffrey J. ;

Somer, Robert A. ;

Hosoya, Hitomi ;

Squillante, Christian .

CLINICAL GENITOURINARY CANCER, 2017, 15 (05) :E847-E849

[10] Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma [J].

Maurice, Catherine ;

Schneider, Raphael ;

Kiehl, Tim-Rasmus ;

Bavi, Prashant ;

Roehrl, Michael H. A. ;

Mason, Warren P. ;

Hogg, David .

CANCER IMMUNOLOGY RESEARCH, 2015, 3 (12) :1299-1302

← 1 2 →